Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft-Part Sarcoma.

Lewin J, Davidson S, Anderson ND, Lau BY, Kelly J, Tabori U, Salah S, Butler MO, Aung KL, Shlien A, Dickson BC, Abdul Razak AR.

Cancer Immunol Res. 2018 Sep;6(9):1001-1007. doi: 10.1158/2326-6066.CIR-18-0037. Epub 2018 Jul 17.


A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours.

Aung KL, El-Khoueiry AB, Gelmon K, Tran B, Bajaj G, He B, Chen T, Zhu L, Poojary S, Basak S, Qi Z, Spreafico A, Fischer BS, Desai J.

Invest New Drugs. 2018 Dec;36(6):1026-1036. doi: 10.1007/s10637-018-0597-6. Epub 2018 Apr 10.


Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial.

Aung KL, Fischer SE, Denroche RE, Jang GH, Dodd A, Creighton S, Southwood B, Liang SB, Chadwick D, Zhang A, O'Kane GM, Albaba H, Moura S, Grant RC, Miller JK, Mbabaali F, Pasternack D, Lungu IM, Bartlett JMS, Ghai S, Lemire M, Holter S, Connor AA, Moffitt RA, Yeh JJ, Timms L, Krzyzanowski PM, Dhani N, Hedley D, Notta F, Wilson JM, Moore MJ, Gallinger S, Knox JJ.

Clin Cancer Res. 2018 Mar 15;24(6):1344-1354. doi: 10.1158/1078-0432.CCR-17-2994. Epub 2017 Dec 29.


Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study.

Ott PA, Bang YJ, Berton-Rigaud D, Elez E, Pishvaian MJ, Rugo HS, Puzanov I, Mehnert JM, Aung KL, Lopez J, Carrigan M, Saraf S, Chen M, Soria JC.

J Clin Oncol. 2017 Aug 1;35(22):2535-2541. doi: 10.1200/JCO.2017.72.5952. Epub 2017 May 10.


Testing ERBB2 p.L755S kinase domain mutation as a druggable target in a patient with advanced colorectal cancer.

Aung KL, Stockley TL, Serra S, Kamel-Reid S, Bedard PL, Siu LL.

Cold Spring Harb Mol Case Stud. 2016 Sep;2(5):a001016. doi: 10.1101/mcs.a001016.


Cascade of care for people living with HIV infection in the Wellington region.

Raymond N, Bargh K, Aung KL, Rice J.

N Z Med J. 2016 Apr 1;129(1432):41-51.


Genomically personalized therapy in head and neck cancer.

Aung KL, Siu LL.

Cancers Head Neck. 2016 Jun 9;1:2. doi: 10.1186/s41199-016-0004-y. eCollection 2016. Review.


Metformin for pancreatic cancer.

Aung KL, Moore MJ.

Lancet Oncol. 2015 Jul;16(7):748-9. doi: 10.1016/S1470-2045(15)00029-7. Epub 2015 Jun 8. No abstract available.


Analytical validation of BRAF mutation testing from circulating free DNA using the amplification refractory mutation testing system.

Aung KL, Donald E, Ellison G, Bujac S, Fletcher L, Cantarini M, Brady G, Orr M, Clack G, Ranson M, Dive C, Hughes A.

J Mol Diagn. 2014 May;16(3):343-9. doi: 10.1016/j.jmoldx.2013.12.004. Epub 2014 Mar 12.


Factors associated with severe clinical manifestation of dengue among adults in Thailand.

Aung KL, Thanachartwet V, Desakorn V, Chamnanchanunt S, Sahassananda D, Chierakul W, Pitisuttithum P.

Southeast Asian J Trop Med Public Health. 2013 Jul 4;44(4):602-12.


Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours.

Aung KL, Board RE, Ellison G, Donald E, Ward T, Clack G, Ranson M, Hughes A, Newman W, Dive C.

Hugo J. 2010 Dec;4(1-4):11-21. doi: 10.1007/s11568-011-9149-2. Epub 2011 Jan 30.


Adjuvant therapy for pancreatic cancer.

Aung KL, Smith DB, Neoptolemos JP.

Expert Opin Pharmacother. 2007 Oct;8(15):2533-41. Review.


Supplemental Content

Support Center